Kyle Staller, MD, MPH is a gastroenterologist and the director of the Gastrointestinal Motility Laboratory at Mass General. He is also an assistant professor of medicine at Harvard Medical School and a member of the Clinical and Translational Epidemiology Unit. Dr. Staller specializes in disorders of gastrointestinal motility and disorders of brain-gut interaction.
Dr. Staller received his medical degree from Harvard Medical School and trained at Massachusetts General Hospital (MGH) for residency and gastroenterology (GI) fellowship. He also completed formal training in epidemiology culminating in a Masters of Public Health from the Harvard School of Public Health and subspecialty training in neurogastroenterology and motility at MGH before joining the faculty.
Dr. Staller’s research interests include clinical and epidemiologic research in neurogastroenterology and motility with particular interest in chronic constipation, irritable bowel syndrome (IBS), fecal incontinence, eating disorders, and women’s health in functional GI diseases. His research has been published in medical journals across the spectrum of GI, and he also serves as a medical liaison to the media with appearances in national news outlets as well as health and wellness magazines.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2000
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr Staller's clinical research program focuses on clinical and epidemiologic research in neurogastroenterology and motility, specifically the epidemiology of irritable bowel syndrome and chronic constipation, early life risk factors for irritable bowel syndrome, physiologic characterization of chronic constipation and bloating, the differential effects of gender on functional GI disease, the intersection between eating disorders and GI symptoms, the role of dietary and lifestyle factors in fecal incontinence, and women's health in functional GI disease.
He serves as an investigator in the MGH Clinical and Translational Epidemiology Unit (CTEU), a home for investigators from multiple disciplines using epidemiology to advance the understanding of chronic disease. He is also a member of the newly-formed Center for Neurointestinal Disease at MGH, a multidisciplinary group of gastroenterologists and surgeons dedicated to the advancement of the science underpinning disorders of GI motility and combining expertise in epidemiology, clinical research, translational research, and basic science into one group.
Publications (link to Pub Med): https://www.ncbi.nlm.nih.gov/pubmed/?term=Staller+K
